Ken Griffin’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $105M | Buy |
4,387,127
+689,001
| +19% | +$16.8M | 0.02% | 774 |
|
|
2025
Q4 | $83.7M | Sell |
3,698,126
-1,145,254
| -24% | -$24.9M | 0.01% | 980 |
|
|
2025
Q3 | $97.5M | Sell |
4,843,380
-8,857,401
| -65% | -$148M | 0.01% | 868 |
|
|
2025
Q2 | $196M | Buy |
13,700,781
+6,834,414
| +100% | +$79.9M | 0.03% | 424 |
|
|
2025
Q1 | $72.1M | Buy |
6,866,367
+5,252,673
| +326% | +$59.4M | 0.01% | 882 |
|
|
2024
Q4 | $19.5M | Sell |
1,613,694
-5,880,605
| -78% | -$76.9M | ﹤0.01% | 2183 |
|
|
2024
Q3 | $110M | Sell |
7,494,299
-5,285,434
| -41% | -$73.6M | 0.02% | 644 |
|
|
2024
Q2 | $184M | Buy |
12,779,733
+698,005
| +6% | +$11.2M | 0.04% | 373 |
|
|
2024
Q1 | $197M | Buy |
12,081,728
+1,859,620
| +18% | +$29.1M | 0.04% | 383 |
|
|
2023
Q4 | $152M | Sell |
10,222,108
-3,593,495
| -26% | -$40.7M | 0.03% | 467 |
|
|
2023
Q3 | $155M | Buy |
13,815,603
+559,193
| +4% | +$6.49M | 0.03% | 408 |
|
|
2023
Q2 | $133M | Buy |
13,256,410
+9,602,677
| +263% | +$89.1M | 0.03% | 467 |
|
|
2023
Q1 | $34.3M | Buy |
3,653,733
+1,191,064
| +48% | +$14.1M | 0.01% | 1413 |
|
|
2022
Q4 | $30.1M | Sell |
2,462,669
-8,322,076
| -77% | -$104M | 0.01% | 1552 |
|
|
2022
Q3 | $134M | Buy |
10,784,745
+10,239,562
| +1,878% | +$179M | 0.03% | 456 |
|
|
2022
Q2 | $10.7M | Sell |
545,183
-50,132
| -8% | -$1.19M | ﹤0.01% | 2598 |
|
|
2022
Q1 | $15.5M | Sell |
595,315
-607,141
| -50% | -$16.2M | ﹤0.01% | 2310 |
|
|
2021
Q4 | $34.1M | Sell |
1,202,456
-188,527
| -14% | -$5.86M | 0.01% | 1495 |
|
|
2021
Q3 | $44.4M | Sell |
1,390,983
-66,675
| -5% | -$2.24M | 0.01% | 1230 |
|
|
2021
Q2 | $50.6M | Sell |
1,457,658
-183,818
| -11% | -$6.06M | 0.01% | 1114 |
|
|
2021
Q1 | $48.3M | Sell |
1,641,476
-986,955
| -38% | -$30.4M | 0.01% | 1069 |
|
|
2020
Q4 | $80.6M | Buy |
2,628,431
+2,508,431
| +2,090% | +$76.5M | 0.02% | 665 |
|
|
2020
Q3 | $3.35M | Buy |
120,000
+6,129
| +5% | +$155K | ﹤0.01% | 3795 |
|
|
2020
Q2 | $2.44M | Sell |
113,871
-334,263
| -75% | -$7.38M | ﹤0.01% | 4209 |
|
|
2020
Q1 | $10M | Sell |
448,134
-195,206
| -30% | -$5.35M | ﹤0.01% | 1848 |
|
|
2019
Q4 | $18.9M | Sell |
643,340
-200,814
| -24% | -$5.46M | 0.01% | 1537 |
|
|
2019
Q3 | $22.4M | Sell |
844,154
-1,346,529
| -61% | -$40.4M | 0.01% | 1365 |
|
|
2019
Q2 | $74M | Sell |
2,190,683
-5,641,514
| -72% | -$183M | 0.03% | 528 |
|
|
2019
Q1 | $251M | Buy |
+7,832,197
| New | +$241M | 0.12% | 105 |
|
|
2018
Q4 | – | Sell |
-861,842
| Closed | -$30.1M | – | 9253 |
|
|
2018
Q3 | $30.1M | Buy |
+861,842
| New | +$30.3M | 0.01% | 1085 |
|
Other funds holding ELAN
VPM
VCM
Ken Griffin's ELAN Position: Q1 2026 in Review
Ken Griffin increased its Elanco Animal Health (ELAN) stake by 19% in Q1 2026, buying an estimated $16.8M and bringing the position to 4,387,127 shares worth $105M. The position accounts for 0.02% of the portfolio, ranked #774.
Ken Griffin first reported a position in ELAN in Q3 2018 and has held it in 30 quarters since. The position peaked at $251M in Q1 2019. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- Ken Griffin held 4,387,127 shares of Elanco Animal Health worth $105M as of Q1 2026.
- Ken Griffin bought 689,001 Elanco Animal Health shares in Q1 2026, an estimated $16.8M.
- Elanco Animal Health made up 0.02% of Ken Griffin's portfolio in Q1 2026, its #774 holding.
- Ken Griffin first reported a position in Elanco Animal Health in Q3 2018 and has held it in 30 quarters since.
- Ken Griffin's Elanco Animal Health position peaked at $251M in Q1 2019.
- 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.